Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 431.43B P/E 72.14 EPS this Y 118.00% Ern Qtrly Grth 66.80%
Income 6.14B Forward P/E 42.44 EPS next Y 39.80% 50D Avg Chg 1.00%
Sales 35.93B PEG 0.94 EPS past 5Y -3.09% 200D Avg Chg 19.00%
Dividend 1.00% Price/Book 36.52 EPS next 5Y 62.63% 52W High Chg -3.00%
Recommedations 2.00 Quick Ratio 0.67 Shares Outstanding 0.95B 52W Low Chg 53.00%
Insider Own 0.16% ROA 12.60% Shares Float 898.20M Beta 0.37
Inst Own 83.84% ROE 50.75% Shares Shorted/Prior 5.40M/5.54M Price 454.48
Gross Margin 80.16% Profit Margin 17.08% Avg. Volume 2,662,108 Target Price 859.23
Oper. Margin 31.20% Earnings Date Aug 8 Volume 2,365,805 Change 0.31%
About Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Eli Lilly and Company News
09:00 AM Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
08:00 AM Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
06:20 AM Dow Jones Futures Fall, But Nvidia Leads Techs Higher; 7 Stocks Near Buy Points
05:04 AM Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows
03:39 AM Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
05/27/24 Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
05/27/24 Lilly doubles investment in Indiana site to enhance API manufacturing
05/26/24 Got $500? 3 Pharma Stocks to Buy and Hold Forever
05/26/24 Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
05/25/24 The Biggest Publicly Traded Biotech Company
05/25/24 3 High-Flying Stocks That Could Soar Even More
05/24/24 Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
05/24/24 Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
05/24/24 Eli Lilly to Invest Another $5.3 Billion in Indiana Manufacturing Site
05/24/24 Ether ETF approved, Live Nation antitrust suit: Morning Brief
05/24/24 Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
05/24/24 Stocks open in the green, Dow hopeful to claw back losses
05/24/24 Lilly invests further $5.3 billion in new Indiana site as obesity drug demand soars
05/24/24 Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
05/24/24 Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
LLY Chatroom

User Image Flabslab Posted - 2 minutes ago

$LLY This stock is as bipolar as my first wife!

User Image zeno123 Posted - 56 minutes ago

I do feel sad for future generations. The investment in technologies is focused on $LLY drugs for obesity over healthy dietary habits and $NVDA artificial intelligence over organic intelligence. I suppose $META social media was the clue, now 20 years in the rearview mirror. Witnessing in realtime wealth expansion in $SPY markets for declining humanity and dystopia.

User Image angelinvesting369 Posted - 1 hour ago

$LLY $NVO $HIMS all in hims as mkt cap is tiny in comparison

User Image fani22 Posted - 1 hour ago

$NVO $HIMS $22.00 next level $LLY

User Image Ibiolegends Posted - 1 hour ago

$LLY $NVO $HIMS

User Image Remriel Posted - 2 hours ago

$NVO $LLY ozempic etf $OZEM

User Image Jacecaudwell Posted - 2 hours ago

$HIMS I love how $NVO $LLY are down. Time to undercut the market!

User Image Smokeyputs69 Posted - 2 hours ago

$LLY that’s a big v

User Image BestRegards Posted - 2 hours ago

$HIMS man I'm thinking more like $100+ after it pulls an $LLY

User Image StockDudeIndy Posted - 2 hours ago

$LLY I’m noticing that every pharmaceutical stock is way down today. Is it because of Biden and him trying to regulate prices?

User Image JFDI Posted - 3 hours ago

gift drop $LLY

User Image Flabslab Posted - 3 hours ago

$LLY Man someone is selling huge.

User Image 1Kof Posted - 3 hours ago

$LLY why this crazy drop !

User Image KitchenParty Posted - 3 hours ago

$LLY $NVO $VANI

User Image 1Kof Posted - 3 hours ago

$LLY dumps like nothing else

User Image impact80 Posted - 3 hours ago

$LLY Why drop?

User Image LieutenantJoe Posted - 3 hours ago

$ELTP the big question is going to be. Does it get bought out or does Elite Pharmaceuticals keep growing organically into an Eventual BP. $LLY $JNJ

User Image harmongreg Posted - 5 hours ago

Dragonfly Capital - 4 Trade Ideas for Eli Lilly: Bonus Idea https://dragonflycap.com/4-trade-ideas-for-eli-lilly-bonus-idea-10/ $LLY and link to Summer Sale!

User Image Stoxpo Posted - 6 hours ago

Breakthrough in Feline Health: Vivani’s $VANI OKV-119 Implant Shows Promise Read more here: https://stoxpo.com/index.php/2024/05/28/breakthrough-in-feline-health-vivanis-okv-119-implant-shows-promise/ $VANI $QQQ $LLY $NVO

User Image impact80 Posted - 6 hours ago

$LLY Weight-loss drug forecasts jump to $150 billion as supply grows

User Image Flabslab Posted - 6 hours ago

$LLY 825?

User Image Ibiolegends Posted - 11 hours ago

$HIMS Expecting 20/usd. EOW. We have a very cheap version of the "most wanted" drug in the world. Awareness is Key. I have to say - Andrew is killing it in that area. I am very "Overweight" in this stock and will continue buying the "dips". The interview with $NVO CEO last week really gave it away! As he stated "We are very aware of Hims" This is one of the biggest companies in the world! $NVO and $LLY have also cleary stated the production ramp up will take years.! I expect $HIMS will make BANK in 2024,2025 and 2026 at the minimum! This is a highly undervalued company!

User Image 0xTrader Posted - 14 hours ago

$LLY insiders are selling off

User Image SPACMEN Posted - 17 hours ago

$HIMS This is going to 40 by EOY. Wall street loves GLP-1 and compounded formulations will available until supply issues are sorted out, which won't happen until at least 2026-2027. Owners of $NVO and $LLY will hedge their investments in case compounded GLP-1 undercut their bottom line.

User Image TX1983 Posted - 1 day ago

@ExplorationalTrades sometimes it pays to be early. By the time there are answers to all this questions, stock could be at $100. I personally missed $LLY when there were rumors of drug. Won’t miss this one

User Image traderGG Posted - 1 day ago

$HIMS With $LLY and $NVO being obvious winners, the race now will be to find secondary players in the GLP-1 insanity. Outside of AI related, this appears to be the theme that will offer massive massive returns to the winners. $NVO is an old school quiet Danish pharma that now has the largest market cap of any European stock. And there recent news about GLP-1 helping with chronic kidney disease is massive. Not being a doctor or scientist, but logically it would seem that reducing one’s weight from obese to normal has massive health benefits. For many ailments. $HIMS can be a big winner with there recently announced $199 bio similar product. I wouldn’t be surprised if there next announcement is that several million people have signed up.

User Image nocap3s Posted - 1 day ago

$LLY one word: Tirzepatide 💊💊💊💊💊💊💊

User Image My_Iphone_Moment Posted - 1 day ago

$HIMS surely will take market share from $LLY

User Image topstockalerts Posted - 2 days ago

$LLY How digital health companies are capitalizing on the GLP-1 boom https://www.cnbc.com/2024/05/25/digital-health-companies-are-launching-programs-around-glp-1s-.html

User Image Ridiculous78 Posted - 2 days ago

$VIGL — Backed by AMGEN, data soon for oral small-molecule TREM2 targeting therapy. $ANVS $BIIB $LLY

Analyst Ratings
Argus Research Buy May 14, 24
BMO Capital Outperform May 1, 24
JP Morgan Overweight May 1, 24
Cantor Fitzgerald Overweight May 1, 24
Truist Securities Buy May 1, 24
Cantor Fitzgerald Overweight Apr 30, 24
Cantor Fitzgerald Overweight Apr 18, 24
Cantor Fitzgerald Overweight Apr 15, 24
Goldman Sachs Neutral Apr 11, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LILLY ENDOWMENT INC Director Director Jan 16 Sell 645.86 1,180 762,115 99,542,630 01/17/24
LILLY ENDOWMENT INC Director Director Jan 04 Sell 630.65 14,388 9,073,792 99,754,422 01/05/24
LILLY ENDOWMENT INC Director Director Aug 08 Sell 521.62 204,409 106,623,823 100,823,810 08/09/23
LILLY ENDOWMENT INC Director Director Jul 21 Sell 466.621 591 275,773 101,028,219 07/24/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 29 Sell 465.083 44,115 20,517,137 101,192,935 06/30/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 22 Sell 458.99 107,022 49,122,028 101,248,810 06/23/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 21 Sell 454.54 31,454 14,297,101 101,355,832 06/22/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 15 Sell 454.59 27,353 12,434,400 101,446,457 06/16/23
LILLY ENDOWMENT INC 10% Owner 10% Owner May 19 Sell 444.92 194,354 86,471,982 101,473,810 05/22/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 06 Sell 367.21 130,297 47,846,361 102,133,810 04/07/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 05 Sell 363.72 69,703 25,352,375 102,264,107 04/06/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 31 Sell 342.71 205,000 70,255,550 102,543,810 04/03/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Dec 02 Sell 372.97 49,089 18,308,724 102,948,810 12/05/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Dec 01 Sell 373.31 160,911 60,069,685 102,997,899 12/02/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Nov 07 Sell 364.42 63,585 23,171,646 103,158,810 11/08/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Nov 02 Sell 362.07 6,131 2,219,851 103,357,679 11/03/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 18 Sell 334.29 12,042 4,025,520 103,529,293 10/19/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 14 Sell 334.42 3,187 1,065,797 103,620,959 10/17/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 06 Sell 336.56 149,264 50,236,292 103,624,546 10/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Sep 28 Sell 336.99 101,631 34,248,631 103,773,810 09/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 28 Sell 333.18 89,458 29,805,616 103,875,441 07/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 26 Sell 332.524 1,601 532,371 103,964,899 07/27/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 15 Sell 334 17,310 5,781,540 103,966,500 07/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 06 Sell 330.88 177,243 58,646,164 103,983,810 07/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 28 Sell 329.01 900 296,109 104,161,053 06/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 27 Sell 329.045 41,857 13,772,837 104,161,953 06/28/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 24 Sell 323.95 215,000 69,649,250 104,203,810 06/27/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 23 Sell 311.37 205,000 63,830,850 104,418,810 06/24/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 22 Sell 307.35 210,000 64,543,500 104,623,810 06/23/22
Zakrowski Donald A Chief Accounting Off.. Chief Accounting Officer Jun 01 Sell 313.44 1,000 313,440 6,274 06/02/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 25 Sell 309.36 41,610 12,872,470 105,212,200 05/26/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 24 Sell 306.01 100,000 30,601,000 105,253,810 05/25/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 23 Sell 303.37 118,856 36,057,345 105,353,810 05/24/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 18 Sell 302.00 700 211,400 105,472,666 05/19/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 17 Sell 302.73 19,683 5,958,635 105,473,366 05/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 16 Sell 302.75 80,761 24,450,393 105,493,049 05/17/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 08 Sell 310.88 139,045 43,226,310 105,573,810 04/11/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 06 Sell 301.11 51,851 15,612,855 105,783,810 04/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 05 Sell 294.4 113,756 33,489,766 105,835,661 04/06/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 04 Sell 293.152 39,393 11,548,137 105,949,417 04/05/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 30 Sell 292.03 2,500 730,075 106,154,186 03/31/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 28 Sell 292.155 7,538 2,202,264 106,161,027 03/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 18 Sell 288.4 210,000 60,564,000 106,203,810 03/21/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 17 Sell 283.95 220,000 62,469,000 106,413,810 03/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 15 Sell 273.77 220,075 60,249,933 106,633,810 03/16/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 14 Sell 269.73 173,085 46,686,217 106,853,885 03/15/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 11 Sell 269.047 21,840 5,875,986 107,026,970 03/14/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 10 Sell 266.8 184,982 49,353,198 107,048,810 03/11/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 09 Sell 266.94 20,018 5,343,605 107,233,792 03/10/22
Runge Marschall S Director Director Mar 01 Buy 246.78 202 49,850 15,436 03/07/22